Skip to main content
Top
Published in: Clinical Rheumatology 12/2009

01-12-2009 | Brief Report

Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis

Authors: Jung Hoei Ku, Choon Key Lee, Bo Sun Joo, Byeong Min An, Seung Hyun Choi, Tae Hyun Wang, Hyung Lae Cho

Published in: Clinical Rheumatology | Issue 12/2009

Login to get access

Abstract

Leptin is known to play an important role in the pathophysiology of osteoarthritis (OA). This study investigated whether synovial fluid (SF) leptin level is related to the radiographic severity of OA and its role as a quantitative marker for the detection of OA. SF was obtained from 42 OA patients who underwent knee surgery and 10 who had no abnormality of articular cartilage during arthroscopic examination. The progression of OA was classified by Kellgren–Lawrence grading scale. The concentrations of leptin were measured with commercial enzyme-linked-immunosorbent serologic assay kits. Median leptin concentrations in SF were significantly higher in OA patients (median 4.40 ng/ml; range 0.5–15.8) compared to controls (median 2.05 ng/ml; range 1.0–4.6; P = 0.006). SF leptin levels showed significant difference according to the severity of OA (P = 0.0125). Median SF leptin level was highest in stage IV patients (11.1 ng/ml), which was significantly higher compared to all other groups including controls (P < 0.05). Age showed a significant positive correlation with leptin concentrations in OA patients (P < 0.05), but not in controls. These results demonstrate that SF leptin concentrations were closely related to the radiographic severity of OA, suggesting that SF leptin levels could be used as an effective marker for quantitative detection of OA.
Literature
1.
go back to reference Garnero P, Landewe R, Boers M et al (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 11:2847–2856CrossRef Garnero P, Landewe R, Boers M et al (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 11:2847–2856CrossRef
2.
go back to reference Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502CrossRefPubMed Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502CrossRefPubMed
3.
go back to reference Dahlberg L, Ryd L, Heinegard D, Lohmander LS (2003) Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 4:417–423 Dahlberg L, Ryd L, Heinegard D, Lohmander LS (2003) Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 4:417–423
4.
go back to reference Maiotti M, Monteleone G, Tarantino U, Fasciglione GF, Marini S, Coletta M (2000) Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 5:522–526CrossRef Maiotti M, Monteleone G, Tarantino U, Fasciglione GF, Marini S, Coletta M (2000) Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 5:522–526CrossRef
5.
go back to reference Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 3:R208–R212CrossRef Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 3:R208–R212CrossRef
6.
go back to reference Chambers MG, Bayliss MT, Mason RM (1997) Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 5:301–308CrossRefPubMed Chambers MG, Bayliss MT, Mason RM (1997) Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 5:301–308CrossRefPubMed
7.
go back to reference Goldenberg MM (1999) Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1:75–87CrossRef Goldenberg MM (1999) Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1:75–87CrossRef
8.
go back to reference Webb GR, Westacott CI, Elson CJ (1997) Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 6:427–437CrossRef Webb GR, Westacott CI, Elson CJ (1997) Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 6:427–437CrossRef
9.
go back to reference Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 4:254–272CrossRef Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 4:254–272CrossRef
10.
go back to reference Chehab FF, Mounzih K, Lu R, Lim ME (1997) Early onset of reproductive function in normal female mice treated with leptin. Science 5296:88–90CrossRef Chehab FF, Mounzih K, Lu R, Lim ME (1997) Early onset of reproductive function in normal female mice treated with leptin. Science 5296:88–90CrossRef
11.
go back to reference Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 5383:1683–1686CrossRef Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 5383:1683–1686CrossRef
12.
go back to reference Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197CrossRefPubMed Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B (2001) Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 287:190–197CrossRefPubMed
13.
go back to reference Dumond H, Presle N, Terlain B et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129CrossRef Dumond H, Presle N, Terlain B et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129CrossRef
14.
go back to reference Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 1:25–33CrossRef Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB (2000) Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 1:25–33CrossRef
15.
go back to reference Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP (1993) Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1:44–50CrossRef Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP (1993) Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1:44–50CrossRef
16.
go back to reference Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65:312–315CrossRefPubMed Teichtahl AJ, Wluka AE, Proietto J, Cicuttini FM (2005) Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65:312–315CrossRefPubMed
17.
go back to reference Simopoulou T, Malizos KN, Iliopoulos D et al (2007) Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 8:872–883CrossRef Simopoulou T, Malizos KN, Iliopoulos D et al (2007) Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 8:872–883CrossRef
18.
go back to reference Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237–246PubMed Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39:237–246PubMed
19.
go back to reference Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 3:585–594CrossRef Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 3:585–594CrossRef
20.
go back to reference Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 2:404–409CrossRef Otero M, Gomez Reino JJ, Gualillo O (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 2:404–409CrossRef
21.
go back to reference Otero M, Lago R, Lago F, Reino JJ, Gualillo O (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 3:R581–R591CrossRef Otero M, Lago R, Lago F, Reino JJ, Gualillo O (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 3:R581–R591CrossRef
22.
go back to reference Uesaka S, Nakayama Y, Yoshihara K, Ito H (2002) Significance of chondroitin sulfate isomers in the synovial fluid of osteoarthritis patients. J Orthop Sci 2:232–237CrossRef Uesaka S, Nakayama Y, Yoshihara K, Ito H (2002) Significance of chondroitin sulfate isomers in the synovial fluid of osteoarthritis patients. J Orthop Sci 2:232–237CrossRef
23.
go back to reference Blum WF, Englaro P, Hanitsch S et al (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 9:2904–2910CrossRef Blum WF, Englaro P, Hanitsch S et al (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 9:2904–2910CrossRef
24.
go back to reference Hickey MS, Israel RG, Gardiner SN et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 1:1–6CrossRef Hickey MS, Israel RG, Gardiner SN et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med 1:1–6CrossRef
Metadata
Title
Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis
Authors
Jung Hoei Ku
Choon Key Lee
Bo Sun Joo
Byeong Min An
Seung Hyun Choi
Tae Hyun Wang
Hyung Lae Cho
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1242-8

Other articles of this Issue 12/2009

Clinical Rheumatology 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.